2025
SJR Q2
JCR Q2 · 3,5
7 eşleşen makale
SCIE
Dergi ayrıntısı
Cellular and Molecular Bioengineering
- Yayıncı
- Springer
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
1865502518655033
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,704
- Quartile Q2
- H-Index 51
- Atıf/yayın 3,51
- Doküman (3y) 130
- Atıf (3y) 467
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,5
- 5Y JIF 3
- JCI 0,46
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Biochemistry, Genetics and Molecular Biology (miscellaneous) Q2
- Modeling and Simulation Q2
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Mathematics
WoS kategorileri
- Cell & Tissue Engineering | Biophysics | Cell Biology | Engineering, Biomedical
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,704 | 3,5 | 3 | 0,46 | Q3 | 51 |
| 2024 | Q2 | Q1 | 0,675 | 5 | 3,4 | 0,45 | Q3 | 48 |
| 2023 | Q2 | Q3 | 0,575 | 2,3 | 2,3 | 0,5 | Q3 | 48 |
| 2022 | Q2 | Q3 | 0,734 | 2,8 | 2,6 | 0,53 | Q3 | 48 |
| 2021 | Q2 | Q3 | 0,677 | 3,3 | 3,7 | 0,56 | Q3 | 48 |
| 2020 | Q2 | Q3 | 0,668 | 2,3 | 2,9 | 0,49 | Q3 | 48 |
| 2019 | Q1 | Q3 | 0,876 | 1,7 | 2,4 | 0,55 | Q3 | 48 |
| 2018 | — | Q2 | — | 2,5 | 2,4 | 0,61 | Q3 | — |
| 2017 | Q1 | Q3 | 1,123 | 2,4 | 2,2 | 0,64 | Q3 | 48 |
| 2016 | Q1 | Q2 | 1,182 | 2,5 | 1,8 | — | — | 48 |
| 2015 | Q2 | Q3 | 0,755 | 1,6 | 1,4 | — | — | 48 |
| 2014 | Q2 | Q4 | 0,733 | 1,3 | 1,6 | — | — | 48 |
| 2013 | Q2 | Q4 | 0,668 | 1,2 | 1,7 | — | — | 48 |
| 2012 | Q1 | Q4 | 0,863 | 1,4 | 1,8 | — | — | 48 |
| 2011 | Q1 | Q3 | 0,842 | 1,9 | 2 | — | — | 48 |
| 2010 | Q2 | Q4 | 0,605 | 1,6 | 1,6 | — | — | 48 |
| 2009 | — | Q4 | — | 0,7 | 0,7 | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | BIOPHYSICS | SCIE | Q2 | Q3 | 24/81 |
| 2025 | CELL BIOLOGY | SCIE | Q3 | Q3 | 118/207 |
| 2025 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q3 | 20/32 |
| 2025 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q3 | 60/130 |
| 2024 | BIOPHYSICS | SCIE | Q1 | Q3 | 10/79 |
| 2024 | CELL BIOLOGY | SCIE | Q2 | Q3 | 63/204 |
| 2024 | CELL & TISSUE ENGINEERING | SCIE | Q1 | Q4 | 8/32 |
| 2024 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | Q3 | 31/124 |
| 2023 | BIOPHYSICS | SCIE | Q3 | Q3 | 48/77 |
| 2023 | CELL BIOLOGY | SCIE | Q4 | Q3 | 162/205 |
| 2023 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 26/31 |
| 2023 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 76/123 |
| 2022 | BIOPHYSICS | SCIE | Q3 | Q3 | 41/70 |
| 2022 | CELL BIOLOGY | SCIE | Q4 | Q3 | 145/191 |
| 2022 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q3 | 23/29 |
| 2022 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 63/96 |
| 2021 | BIOPHYSICS | SCIE | Q3 | Q3 | 38/72 |
| 2021 | CELL BIOLOGY | SCIE | Q3 | Q3 | 141/195 |
| 2021 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q3 | 23/29 |
| 2021 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 59/98 |
| 2020 | BIOPHYSICS | SCIE | Q3 | Q3 | 50/71 |
| 2020 | CELL BIOLOGY | SCIE | Q4 | Q3 | 162/195 |
| 2020 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 26/29 |
| 2020 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 63/89 |
| 2019 | BIOPHYSICS | SCIE | Q4 | Q3 | 55/71 |
| 2019 | CELL BIOLOGY | SCIE | Q4 | Q3 | 169/195 |
| 2019 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q3 | 27/29 |
| 2019 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 63/87 |
| 2018 | BIOPHYSICS | SCIE | Q3 | Q3 | 40/73 |
| 2018 | CELL BIOLOGY | SCIE | Q3 | Q3 | 139/193 |
| 2018 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q3 | 20/26 |
| 2018 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q3 | 33/80 |
| 2017 | BIOPHYSICS | SCIE | Q3 | Q3 | 38/72 |
| 2017 | CELL BIOLOGY | SCIE | Q3 | Q3 | 132/190 |
| 2017 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q3 | 18/24 |
| 2016 | BIOPHYSICS | SCIE | Q2 | — | 36/73 |
| 2016 | CELL BIOLOGY | SCIE | Q3 | — | 124/190 |
| 2016 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 18/21 |
| 2015 | BIOPHYSICS | SCIE | Q3 | — | 52/72 |
| 2015 | CELL BIOLOGY | SCIE | Q4 | — | 160/187 |
| 2015 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 18/21 |
| 2014 | BIOPHYSICS | SCIE | Q4 | — | 58/73 |
| 2014 | CELL BIOLOGY | SCIE | Q4 | — | 169/184 |
| 2014 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 19/21 |
| 2013 | BIOPHYSICS | SCIE | Q4 | — | 59/74 |
| 2013 | CELL BIOLOGY | SCIE | Q4 | — | 167/185 |
| 2013 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 16/18 |
| 2012 | BIOPHYSICS | SCIE | Q4 | — | 58/72 |
| 2012 | CELL BIOLOGY | SCIE | Q4 | — | 161/185 |
| 2012 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 14/17 |
| 2011 | BIOPHYSICS | SCIE | Q3 | — | 48/74 |
| 2011 | CELL BIOLOGY | SCIE | Q3 | — | 135/181 |
| 2011 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 12/12 |
| 2010 | BIOPHYSICS | SCIE | Q4 | — | 56/73 |
| 2010 | CELL BIOLOGY | SCIE | Q4 | — | 149/178 |
| 2010 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 12/13 |
| 2009 | BIOPHYSICS | SCIE | Q4 | — | 66/74 |
| 2009 | CELL BIOLOGY | SCIE | Q4 | — | 155/162 |
| 2009 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 11/12 |